{"id":"W2321034066","doi":"10.1097/01.cot.0000416570.49020.3e","title":"Best of ASCO 2012","year":2012,"lang":"en","type":"article","venue":"Oncology Times","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Carfilzomib; Medicine; Lenalidomide; Multiple myeloma; Tolerability; Internal medicine; Thalidomide; Oncology; Plasma cell leukemia; Dexamethasone; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007571811,0.001637735,0.001059007,0.001968174,0.001163731,0.005998649,0.001524656,0.002725273,0.7810388],"category_scores_gemma":[0.002299961,0.000613755,0.001236012,0.001500933,0.0004545715,0.002093836,0.002330979,0.003472524,0.8088994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001006992,"about_ca_system_score_gemma":0.00118108,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001186408,"about_ca_topic_score_gemma":0.002330751,"domain_scores_codex":[0.9992854,0.00006938296,0.00004079207,0.000172427,0.0003345994,0.0000973999],"domain_scores_gemma":[0.9989422,0.0001033997,0.00004988733,0.0001109499,0.00040086,0.0003927233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004563987,0.00007194842,0.0001357116,0.0002161288,0.00000835884,0.0001249763,0.00001041534,0.00006817412,0.0004039796,0.0007398654,0.8765126,0.1216622],"study_design_scores_gemma":[0.00002150666,0.00001365226,0.000214664,0.000105919,0.000003172949,0.0001411827,0.000008161706,0.00004515952,0.0000572012,0.00022853,0.999157,0.000003958957],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"review","genre_scores_codex":[0.0006703332,0.01090508,0.001837007,0.009015533,0.02901859,0.0003622515,0.005198229,0.002076873,0.9409161],"genre_scores_gemma":[0.001518171,0.005899679,0.0006668821,0.004437562,0.004523242,0.0001245273,0.004668092,0.000380688,0.9777811],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.7810388,"threshold_uncertainty_score":0.3123216,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04620166454705379,"score_gpt":0.3837018831152496,"score_spread":0.3375002185681958,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}